ThinkBio.Ai® Joins Mayo Clinic Platform Accelerate June 2026 Cohort

ThinkBio.Ai®, a knowledge-driven AI company focused on transforming complex biological and clinical data into actionable insights, is proud to be part of the Mayo Clinic Platform Accelerate June 2026 Cohort.

Representing ThinkBio.Ai®, Apurva Kalia and John Rakesh participated in the cohort onboarding, engaging with Mayo Clinic Platform experts, healthcare innovators, and members of the broader healthcare technology ecosystem.

The program provides ThinkBio.Ai® with an opportunity to explore and refine approaches to two important challenges in clinical health management: AI-driven care planning and trial-to-patient matching.

At ThinkBio.Ai®, we are focused on developing clinical health solutions from multi-variable, multi-modal data complemented with clinical expertise. Addressing complex healthcare challenges requires more than bringing together diverse datasets; It also requires a clear understanding of real-world clinical needs and how AI can effectively support existing healthcare workflows.

Through the Mayo Clinic Platform Accelerate program, ThinkBio.Ai® is exploring the capabilities of the Mayo Clinic Platform, learned from clinical and healthcare technology experts, and connected with a community focused on advancing healthcare innovation.

As part of this program, ThinkBio.Ai® is further exploring how diverse biological and clinical data can be integrated to generate meaningful insights and support more informed, data-driven healthcare.

The experience provides valuable perspectives as ThinkBio.Ai® continues to develop AI-driven approaches for clinical health and strengthen its ability to translate complex data into solutions aligned with real-world healthcare needs.

About ThinkBio.Ai®

ThinkBio.Ai® is a knowledge-driven AI company purpose-built to enable biopharma to achieve a faster, shorter development cycle for bringing drugs to market at scale. We address the preclinical and clinical success of drugs by integrating production-ready proprietary multi-scale biomedical knowledge graphs and foundation models to identify hidden biological signals that can help identify at-risk clinical programs early. By shaping the process of early decision-making, we aim to transform the economics of drug development.

Our capabilities extend across complex biological and clinical data, with a focus on developing AI-driven solutions that support drug development and clinical healthcare. Through our platforms and solutions, ThinkBio.Ai® brings together biological knowledge, clinical data, AI/ML, knowledge graphs, and digital twins to generate explainable insights that can support more informed research and healthcare decisions.

Watch the ThinkBio.Ai® Accelerate Cohort Video